FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing ...

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a generative AI-based system for speeding up drug review - and plans to roll out ...

The goal is to provide executives with an empirical baseline for strategic decisions regarding AI, cutting through the hype ...

Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

The FDA has appointed its first chief artificial intelligence officer, with an eye on supporting the agency’s internal IT ...

The FDA expects to fully integrate its AI approach by June 30, though its different centers have been instructed to start the ...